Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: PTK-PRK refractive treatment.
- Who it may be relevant to
- Registry conditions: Refractive Errors. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- India
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser for Verification of Predicted Refractive Outcome Using EpiMaster Software Considering Epithelial Remodelling
Overview
The objective of the clinical investigation presented to is to verify predictions of post-operative PTK-PRK refractive outcome made by the EpiMaster application software by comparing these to post-operative clinical data after routine PTK-PRK treatments.
Detailed description
The objective of the clinical investigation presented to is to verify predictions of post-operative PTK-PRK refractive outcome made by the EpiMaster application software by comparing these to post-operative clinical data after routine PTK-PRK treatments.
The EpiMaster application software is not used in this clinical investigation, consequently, it is a merely observational investigation.
Interventions
- Procedure PTK-PRK refractive treatment
The PTK-PRK refractive treatment will be done according to routine clinical practice.
Primary outcome measures
- Difference of SE(measured) and SE(predicted by EpiMaster) [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- Inclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors
- Patient present with myopic or myopic and astigmatic error
- Patient will be able to understand the patient information and willing to sign an informed consent
- Patient will be willing to comply with all follow-up visits and the respective examinations
Exclusion criteria
- Exclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
India · 2 centers
- Pro Sight Eye Hospital — Chandigarh
- Uma Eye Clinic — Chennai
Identifiers
NCT: NCT06996353 · LoVC-011